Aileron Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALRN and other ETFs, options, and stocks.

About ALRN

Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company engaged in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. 

CEO
Manuel C. Alves Aivado
CEOManuel C. Alves Aivado
Employees
9
Employees9
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2001
Founded2001
Employees
9
Employees9

ALRN Key Statistics

Market cap
18.05M
Market cap18.05M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.87M
Average volume2.87M
High today
$0.2036
High today$0.2036
Low today
$0.19
Low today$0.19
Open price
$0.2036
Open price$0.2036
Volume
227.72K
Volume227.72K
52 Week high
$1.09
52 Week high$1.09
52 Week low
$0.131
52 Week low$0.131

ALRN Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.